1. Home
  2. REVB vs OBLG Comparison

REVB vs OBLG Comparison

Compare REVB & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$1.15

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Oblong Inc.

OBLG

Oblong Inc.

HOLD

Current Price

$2.69

Market Cap

5.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
OBLG
Founded
2020
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REVB
OBLG
Price
$1.15
$2.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
107.2K
86.7K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,378,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$1.69
52 Week High
$60.48
$5.50

Technical Indicators

Market Signals
Indicator
REVB
OBLG
Relative Strength Index (RSI) 63.48 60.41
Support Level $1.03 $2.07
Resistance Level $1.00 $2.40
Average True Range (ATR) 0.08 0.23
MACD 0.04 0.09
Stochastic Oscillator 93.03 100.00

Price Performance

Historical Comparison
REVB
OBLG

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: